576
Views
7
CrossRef citations to date
0
Altmetric
Research Articles

l-Carnitine ameliorates knee lesions in mono-iodoacetate induced osteoarthritis in ratsFootnoteFootnote

, , , , &
Pages 61-66 | Received 28 Oct 2015, Accepted 07 Mar 2016, Published online: 17 May 2019

References

  • B.J.de Lange-BrokaarA.Ioan-FacsinayG.J.van OschA.M.ZuurmondJ.SchoonesR.E.ToesSynovial inflammation, immune cells and their cytokines in osteoarthritis: a reviewOsteoarthr Cartil2012201214841499
  • M.SowersEpidemiology of risk factors for osteoarthritis: systemic factorsCurr Opin Rheumatol1352001447451
  • I.SulzbacherOsteoarthritis: histology and pathogenesisWien Med Wochenschr1639–102013212219
  • M.MaldonadoJ.NamThe role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritisBiomed Res Int20132013284873
  • N.J.BartonD.A.StevensJ.P.HughesA.G.RossiI.P.ChessellA.J.ReeveDemonstration of a novel technique to quantitatively assess inflammatory mediators and cells in rat knee jointsJ Inflamm4200713
  • M.KapoorJ.Martel-PelletierD.LajeunesseJ.P.PelletierH.FahmiRole of proinflammatory cytokines in the pathophysiology of osteoarthritisNat Rev Rheumatol7120113342
  • B.A.FoxM.M.StephensGlucosamine/chondroitin/primorine combination therapy for osteoarthritisDrugs Today45120092131
  • C.J.ReboucheD.J.PaulsonCarnitine metabolism and function in humansAnnu Rev Nutr619864166
  • Y.CaoY.X.WangC.J.LiuL.X.WangZ.W.HanC.B.WangComparison of pharmacokinetics of l-carnitine, acetyl-l-carnitine and propionyl-l-carnitine after single oral administration of l-carnitine in healthy volunteersClin Invest Med3212009 E13-9
  • C.C.WagnerA.RuscaK.KletterM.TschurlovitsS.PaceA.LongoPlasma pharmacokinetics and gastrointestinal transit of a new propionyl-l-carnitine controlled release formulationXenobiotica41112011988995
  • G.D’AntonaS.M.NabaviP.MichelettiA.Di LorenzoR.AquilaniE.NisoliCreatine, l-carnitine, and omega3 polyunsaturated fatty acid supplementation from healthy to diseased skeletal muscleBiomed Res Int20142014613890
  • L.BonafeM.M.BergerY.A.QueJ.I.MechanickCarnitine deficiency in chronic critical illnessCurr Opin Clin Nutr Metab Care1722014200209
  • S.G.AKirkhamR.K.SamarasingheReview article: GlucosamineJ Orthop Surg (Hong Kong)17120097276 B.BMalaekeh-Nikouei S.Golmohammadzadeh S.Salmani-Chamanabad N.Mosallaei K.JamialahmadiPreparation, characterization, and moisturizing effect of liposomes containing glucosamine and N-acetyl glucosamineJ Cosmet Dermatol122201396102
  • S.QianQ.ZhangY.WangB.LeeG.V.BetageriM.S.ChowBioavailability enhancement of glucosamine hydrochloride by chitosanInt J Pharm4551–22013365373
  • P.QvistA.C.Bay-JensenC.ChristiansenE.B.DamP.PastoureauM.A.KarsdalThe disease modifying osteoarthritis drug (DMOAD): Is it in the horizon?Pharmacol Res581200817
  • Y.HenrotinC.LambertChondroitin and glucosamine in the management of osteoarthritis: an updateCurr Rheumatol Rep15102013361
  • A.Scotto d’AbuscoV.CalamiaC.CicioneB.GrigoloL.PolitiR.ScandurraGlucosamine affects intracellular signalling through inhibition of mitogen-activated protein kinase phosphorylation in human chondrocytesArthritis Res Ther952007R104
  • J.L.TremoledaA.KertonW.GsellAnaesthesia and physiological monitoring during in vivo imaging of laboratory rodents: considerations on experimental outcomes and animal welfareEJNMMI Res21201244
  • R.E.GuzmanM.G.EvansS.BoveB.MorenkoK.KilgoreMono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritisToxicol Pathol3162003619624
  • M.U.RezendeH.M.GurgelP.R.Vilaca JuniorR.K.KurobaA.S.LopesR.Z.PhillipiDiacerhein versus glucosamine in a rat model of osteoarthritisClinics6152006461466
  • E.BianchiMannelli L.Di CesareC.MenicacciP.LorenzoniM.AglianoC.GhelardiniProphylactic role of acetyl-l-carnitine on knee lesions and associated pain in a rat model of osteoarthritisLife Sci1061–220143239
  • M.KhanM.AshrafA.HashmiM.D.AhmadA.A.AnjumClinical assessment of experimentally induced osteoarthritis rat model in relation to timeAnim Plant Sci2242012960965
  • S.AdaesM.MendoncaT.N.SantosJ.M.Castro-LopesJ.Ferreira-GomesF.L.NetoIntra-articular injection of collagenase in the knee of rats as an alternative model to study nociception associated with osteoarthritisArthritis Res Ther1612014R10
  • M.L.KaushikS.S.JalalpureEffect of Curcuma zedoaria Rosc root extracts on behavioral and radiology changes in arthritic ratsAdv Pharm Technol Res232011170176
  • F.SongK.WisithphromJ.ZhouL.J.WindsorMatrix metalloproteinase dependent and independent collagen degradationFront Biosci11200631003120
  • N.GerwinA.M.BendeleS.GlassonC.S.CarlsonThe OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the ratOsteoarthr Cartil18Suppl. 32010S24S34
  • J.R.LandisG.G.KochThe measurement of observer agreement for categorical dataBiometrics3311977159174
  • C.ChadjichristosC.GhayorM.KypriotouG.MartinE.RenardL.Ala-KokkoSp1 and Sp3 transcription factors mediate interleukin-1 beta down-regulation of human type II collagen gene expression in articular chondrocytesBiol Chem2784120033976239772
  • A.KocT.OzkanA.Z.KarabayA.SungurogluF.AktanEffect of l-carnitine on the synthesis of nitric oxide in RAW 264.7 murine macrophage cell lineCell Biochem Funct2982011679685
  • C.AmalineiI.D.CaruntuS.E.GiuscaR.A.BalanMatrix metalloproteinases involvement in pathologic conditionsRom Morphol Embryol5122010215228
  • J.LeeY.S.HongJ.H.JeongE.J.YangJ.Y.JhunM.K.ParkCoenzyme Q10 ameliorates pain and cartilage degradation in a rat model of osteoarthritis by regulating nitric oxide and inflammatory cytokinesPLoS One872013e69362
  • B.R.DasA.RoyF.R.KhanCartilage oligomeric matrix protein in monitoring and prognostication of osteoarthritis and its utility in drug developmentPerspect Clin Res61201549
  • P.VermaK.DalalSerum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: a novel diagnostic and prognostic biomarkerJ Orthop Res31720139991006
  • Y.LaiX.P.YuY.ZhangQ.TianH.SongM.T.MucignatEnhanced COMP catabolism detected in serum of patients with arthritis and animal disease models through a novel capture ELISAOsteoarthr Cartil2082012854862
  • L.A.JoostenM.M.HelsenT.SaxneF.A.van De LooD.HeinegardW.B.van Den BergIL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammationJ Immunol1639199950495055
  • J.SalazarL.BelloM.ChavezR.AnezJ.RojasV.BermudezGlucosamine for osteoarthritis: biological effects, clinical efficacy, and safety on glucose metabolismArthritis20142014432463